Insulin Family intermediate
Insulin Therapy and Weight Gain
Mechanisms and clinical management of weight gain associated with insulin therapy. This peptide or oligopeptide is studied for its biological activity, struc...
By Encyclopeptide Editorial | 1 min read
insulin weight-gain adiposity metabolic diabetes
Overview
Weight gain is a common side effect of insulin therapy, typically 2-6 kg in the first year. The mechanism involves restoration of anabolic insulin signaling, reduced glycosuria, and appetite stimulation.
Comparative Weight Gain
| Insulin Type | Average Weight Gain |
|---|---|
| NPH | 3-5 kg/year |
| Glargine U100 | 2-4 kg/year |
| Degludec | 1.5-3 kg/year |
| Glargine U300 | 1-3 kg/year |
Mitigation Strategies
- Use of GLP-1 receptor agonists in combination
- Dose optimization to minimize excess
- Patient education on diet and exercise
- Consideration of SGLT2 inhibitor co-therapy
Chemical Identity
| Property | Value |
|---|---|
| Name | Insulin Therapy and Weight Gain |
| Category | Insulin Family |
References
- Encyclopeptide Database. “Insulin Therapy and Weight Gain” monograph. encyclopeptide.com.
Test Your Knowledge
Reinforce what you learned about Insulin Therapy and Weight Gain with interactive quizzes on Wikipept.
Take a Quiz on Wikipept